FDA greenlights 3D-printed cervical spacer system

An established company in the spinal device market has added a 3D-printed vertebral spacer to its line of FDA-cleared products.

Lewisville, Texas-based Orthofix Medical says its latest offering allows neck bone to grow into and through the spacer, helping the patient’s cervical vertebrae to fuse following the spacer’s surgical insertion as a lasting therapy for herniated or degenerative discs.

Called the Construx Mini Ti (for titanium) spacer system, the newly approved technology follows several similar products in Orthofix’s line to win FDA’s OK.

The company says the Mini Ti features 3D-printed porous titanium with macro, micro and nanoscale surface features.

Full announcement here.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.